GlassScriptPhysician profile
Jenna B Sassie
NPI 1063850659
$1,129.09
in general payments reported to CMS, 2019-2025
20 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.66 · 2020: $114 · 2021: $142 · 2022: $293 · 2023: $180 · 2024: $242 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $535.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $257.53 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Mayne Pharma Commercial LLC | $118.91 | 2023-2025 | |
| Pfizer INC. | $111.60 | 2020-2024 | |
| Medtronic, INC. | $98.66 | 2022 | |
| Sumitomo Pharma America, INC. | $56.16 | 2024-2025 | Myfembree |
| Evofem Biosciences, INC. | $54.75 | 2020-2025 | Phexxi, Solosec, Phexx |
| Exeltis, USA INC. | $54.26 | 2023-2025 | Nuvessa, Nuvessa, Slynd |
| Intuitive Surgical, INC. | $52.53 | 2022 | |
| Therapeuticsmd, INC. | $49.21 | 2019-2020 | |
| Millicent US INC | $40.17 | 2023-2024 | Femring, Intrarosa |
| Hologic Sales and Service, LLC | $39.49 | 2021-2024 | Thinprep 2000 Processor, Aptima |
| Avion Pharmaceuticals | $32.22 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $28.63 | 2019-2021 | |
| Smith+Nephew, INC. | $28.13 | 2024 | Pico 7 |
| Astellas Pharma US INC | $27.90 | 2024 | Veozah |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $22.72 | 2023 | Accrufer |
| Novo Nordisk INC | $17.83 | 2024 | Wegovy |
| Agile Therapeutics, INC. | $15.06 | 2023 | Twirla |
| Lupin INC. | $12.18 | 2020 | |
| Coopersurgical, INC. | $11.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Sassie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.